Turk Ilac ve Serum Sanayi AS (TRILC) - Total Liabilities
Based on the latest financial reports, Turk Ilac ve Serum Sanayi AS (TRILC) has total liabilities worth TL4.21 Billion TRY (≈ $94.36 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Turk Ilac ve Serum Sanayi AS - Total Liabilities Trend (2018–2024)
This chart illustrates how Turk Ilac ve Serum Sanayi AS's total liabilities have evolved over time, based on quarterly financial data. See TRILC current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Turk Ilac ve Serum Sanayi AS Competitors by Total Liabilities
The table below lists competitors of Turk Ilac ve Serum Sanayi AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Is Yatirim Ortakligi AS
IS:ISYAT
|
Turkey | TL5.28 Million |
|
BPL Limited
NSE:BPL
|
India | Rs3.28 Billion |
|
LMS Co. Ltd
KQ:073110
|
Korea | ₩85.89 Billion |
|
Plus Therapeutics Inc
NASDAQ:PSTV
|
USA | $12.33 Million |
|
Aveng Ltd
JSE:AEG
|
South Africa | ZAC8.30 Billion |
|
Sow Good Inc. Common Stock
NASDAQ:SOWG
|
USA | $4.50 Million |
|
AJ Bell plc
LSE:AJB
|
UK | GBX85.63 Million |
|
AGES Industri AB (publ)
ST:AGES-B
|
Sweden | Skr370.00 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Turk Ilac ve Serum Sanayi AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Turk Ilac ve Serum Sanayi AS stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Turk Ilac ve Serum Sanayi AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Turk Ilac ve Serum Sanayi AS (2018–2024)
The table below shows the annual total liabilities of Turk Ilac ve Serum Sanayi AS from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | TL2.07 Billion ≈ $46.38 Million |
+98.32% |
| 2023-12-31 | TL1.04 Billion ≈ $23.39 Million |
+117.69% |
| 2022-12-31 | TL479.65 Million ≈ $10.74 Million |
+62.34% |
| 2021-12-31 | TL295.46 Million ≈ $6.62 Million |
+17.71% |
| 2020-12-31 | TL250.99 Million ≈ $5.62 Million |
+24.35% |
| 2019-12-31 | TL201.84 Million ≈ $4.52 Million |
+58.46% |
| 2018-12-31 | TL127.38 Million ≈ $2.85 Million |
-- |
About Turk Ilac ve Serum Sanayi AS
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. Turk Ilac Ve Serum Sanayi Anonim Sirketi was founded in 2010 and is headquartered in Anka… Read more